Global Endoscope Reprocessing Market Size By Type (High-level Disinfectants and Test Strips, Detergents and Wipes), By Application (Hospitals, Ambulatory Surgery Centers), By Region, And Segment Forec...

The Global Endoscope Reprocessing Market was valued at USD 2.1 billion in 2023 and is projected to surpass USD 3.7 billion by 2031, growing at a CAGR of 7.2% during the forecast period from 2023 to 2031. The increasing incidence of endoscopy procedures globally, coupled with the growing awareness regarding infection prevention and patient safety, is driving the demand for endoscope reprocessing systems. Additionally, stringent regulatory guidelines for cleaning and disinfecting endoscopes in healthcare facilities are further fueling market growth.

Endoscope reprocessing plays a crucial role in minimizing cross-contamination risks and ensuring the safety of medical procedures. Technological advancements, including automated endoscope reprocessors (AERs) and eco-friendly disinfectants, are positively influencing the market dynamics.

Drivers

Increasing Adoption of Endoscopy Procedures

The rising prevalence of gastrointestinal, respiratory, and urological disorders has led to a surge in endoscopic procedures worldwide, thereby increasing the demand for endoscope reprocessing equipment to maintain hygiene standards.

Stringent Regulatory Guidelines

Healthcare regulatory bodies such as the FDA, CDC, and European Medicines Agency (EMA) have mandated strict guidelines for the cleaning, disinfection, and sterilization of endoscopes, propelling the adoption of advanced reprocessing systems.

Technological Advancements

Innovations in automated endoscope reprocessing systems and the introduction of eco-friendly, rapid-acting disinfectants are significantly improving reprocessing efficiency and patient safety.

Restraints

High Cost of Advanced Endoscope Reprocessors

The substantial cost associated with automated reprocessing equipment and disinfectants can be a barrier, particularly for small and medium-sized healthcare facilities in developing regions.

Risk of Reprocessing Errors

Despite automation, improper handling, or failure to comply with protocols during reprocessing can lead to infection risks, restraining market growth.

Opportunity

Rising Demand in Emerging Markets

Emerging economies in Asia-Pacific and Latin America offer significant growth opportunities due to improving healthcare infrastructure, increasing healthcare expenditure, and growing awareness about infection control practices.

Integration of Smart Monitoring Systems

The integration of IoT and AI-driven smart monitoring technologies in reprocessing systems presents a lucrative opportunity for market players to enhance efficiency, traceability, and compliance management.

Market by System Type Insights

Based on system type, the Automated Endoscope Reprocessors (AERs) segment accounted for the largest market share in 2023. AERs are preferred due to their ability to provide standardized and efficient cleaning processes, reducing human error and ensuring regulatory compliance.

The Consumables segment, including disinfectants and detergents, is anticipated to witness significant growth owing to the increasing frequency of endoscopic procedures and the recurring need for reprocessing materials.

Market by End-use Insights

By end-use, the Hospitals segment emerged as the largest revenue contributor in 2023, holding over 55% of the market share. The high volume of endoscopic procedures performed in hospitals necessitates reliable and efficient reprocessing solutions to ensure patient safety.

Ambulatory Surgical Centers (ASCs) are expected to exhibit the highest growth rate during the forecast period, driven by the rising preference for outpatient surgical procedures and the need for cost-effective infection control solutions.

Market by Regional Insights

Geographically, North America dominated the global endoscope reprocessing market in 2023, attributed to advanced healthcare infrastructure, stringent infection control regulations, and the high adoption of innovative reprocessing technologies.

Asia-Pacific is anticipated to witness the highest CAGR during the forecast period, supported by the increasing number of healthcare facilities, growing medical tourism, and rising awareness about hospital-acquired infections (HAIs).

Competitive Scenario

Key players operating in the Global Endoscope Reprocessing Market include:

Olympus Corporation

STERIS plc

Getinge AB

Ecolab Inc.

Advanced Sterilization Products (ASP)

Cantel Medical (a Steris Company)

Metrex Research LLC

Wassenburg Medical BV

Belimed AG

Custom Ultrasonics, Inc.

These companies focus on product innovation, mergers & acquisitions, and strategic collaborations to expand their market presence and meet the evolving demands of healthcare providers.

Scope of Work – Global Endoscope Reprocessing Market

Report Metric Details

Market Size (2023) USD 2.1 billion

Projected Market Size (2031) USD 3.7 billion

CAGR (2023-2031) 7.2%

Key Segments by System Type Automated Endoscope Reprocessors (AERs), High-Level Disinfectants, Consumables

Key Segments by End-use Hospitals, Ambulatory Surgical Centers (ASCs), Clinics

Leading Region North America

Key Players Olympus Corporation, STERIS plc, Getinge AB, Ecolab Inc., Cantel Medical, ASP

Market Drivers Rising endoscopy procedures, regulatory compliance, technological advancements

Market Opportunities Emerging markets expansion, smart monitoring systems integration

Key Market Developments

In 2023, Olympus Corporation launched an advanced AER system with integrated smart monitoring capabilities to improve traceability and efficiency.

In 2024, STERIS plc expanded its presence in Asia-Pacific by establishing a new manufacturing facility focused on endoscope reprocessing equipment.

In 2025, Ecolab Inc. introduced an eco-friendly, rapid-action disinfectant designed to meet stringent hospital infection control standards.

FAQs

1. What is the current market size of the Global Endoscope Reprocessing Market?

The market was valued at USD 2.1 billion in 2023.

2. What is the major growth driver of the Global Endoscope Reprocessing Market?

The increasing adoption of endoscopy procedures and stringent infection control regulations are the primary growth drivers.

3. Which is the largest region during the forecast period in the Global Endoscope Reprocessing Market?

North America holds the largest market share due to advanced healthcare infrastructure and regulatory compliance.

4. Which segment accounted for the largest market share in the Global Endoscope Reprocessing Market?

The Automated Endoscope Reprocessors (AERs) segment accounted for the largest market share in 2023.

5. Who are the key market players in the Global Endoscope Reprocessing Market?

Key players include Olympus Corporation, STERIS plc, Getinge AB, Ecolab Inc., Cantel Medical, ASP, and others.